Tischler A S, Powers J F, Shahsavari M, Ziar J, Tsokas P, Downing J, McClain R M
Department of Pathology, Tufts University School of Medicine, Boston, Massachusetts, 02111, USA.
Fundam Appl Toxicol. 1997 Feb;35(2):216-20. doi: 10.1006/faat.1996.2277.
Spontaneous and drug-induced pheochromocytomas are common in rats and rare in mice. The antihypertensive drug reserpine has been shown to both induce pheochromocytomas and stimulate chromaffin cell proliferation in rats, leading to the hypothesis that reserpine causes pheochromocytomas indirectly by providing a proliferative setting in which DNA damage may occur. The present investigation was undertaken to obtain baseline information on the relationship across species between chromaffin cell proliferation and pheochromocytomas. Basal chromaffin cell proliferation was compared in age-matched young adult mice and rats. In addition, mice were studied for adrenal medullary responses to reserpine, and mouse chromaffin cells in vitro were studied for responses to agents that are mitogenic for cultured rat chromaffin cells. Concurrently maintained F-344 rats and several strains of mice showed no significant difference in basal BrdU incorporation over a 1-week period. Mice also showed an adrenal medullary proliferative response to reserpine that was comparable to the response previously reported for rats. However, there was a marked disparity between rat and mouse chromaffin cells in vitro, and cultured mouse chromaffin cells did not respond to any mitogens. The in vivo data indicate that interspecies differences in basal- or reserpine-stimulated chromaffin cell proliferation sufficient to account for different frequencies of pheochromocytomas are not detectable at a single time point in young adult animals. However, the possibility that such differences might emerge with aging has not been ruled out. These data further suggest either that stimulation of chromaffin cell proliferation might be necessary but not sufficient for development of pheochromocytomas or that stimulated proliferation in mice might not be sustained. The inability of cultured mouse chromaffin cells to respond to mitogens raises the speculation of whether mechanisms that prevent proliferation of normal chromaffin cells in vitro might also help to protect mice from developing pheochromocytomas.
自发性和药物诱导性嗜铬细胞瘤在大鼠中很常见,而在小鼠中很少见。抗高血压药物利血平已被证明既能诱导大鼠产生嗜铬细胞瘤,又能刺激大鼠嗜铬细胞增殖,这导致了一种假说,即利血平通过提供一种可能发生DNA损伤的增殖环境间接导致嗜铬细胞瘤。本研究旨在获取关于嗜铬细胞增殖与嗜铬细胞瘤跨物种关系的基线信息。比较了年龄匹配的年轻成年小鼠和大鼠的基础嗜铬细胞增殖情况。此外,研究了小鼠对利血平的肾上腺髓质反应,并在体外研究了小鼠嗜铬细胞对能促使培养的大鼠嗜铬细胞产生有丝分裂的试剂的反应。同时饲养的F-344大鼠和几个品系的小鼠在1周时间内基础溴脱氧尿苷掺入率没有显著差异。小鼠对利血平的肾上腺髓质增殖反应也与先前报道的大鼠反应相当。然而,大鼠和小鼠的嗜铬细胞在体外存在明显差异,培养的小鼠嗜铬细胞对任何有丝分裂原都没有反应。体内数据表明,在年轻成年动物的单个时间点,无法检测到基础或利血平刺激的嗜铬细胞增殖的种间差异足以解释嗜铬细胞瘤的不同发生率。然而,这种差异可能随年龄增长而出现的可能性尚未排除。这些数据进一步表明,要么嗜铬细胞增殖的刺激可能是嗜铬细胞瘤发生所必需的,但不是充分条件,要么小鼠中受刺激的增殖可能无法持续。培养的小鼠嗜铬细胞对有丝分裂原无反应,这引发了一种猜测,即体外阻止正常嗜铬细胞增殖的机制是否也有助于保护小鼠不发生嗜铬细胞瘤。